Kelsie Raspin

6PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 01, 2024
Mitochondrial ribosomal proteins in metastasis and their potential use as prognostic and therapeutic targets.

Jasmine M Bacon, Johanna L Jones, Guei-Sheung Liu

|Aug 21, 2024
WNT5A is a putative epi-driver of prostate cancer metastasis to the bone.

Emma J Wilkinson, Kelsie Raspin, Roslyn C Malley

|Apr 06, 2021
A rare variant in EZH2 is associated with prostate cancer risk.

Kelsie Raspin, Liesel M FitzGerald, James R Marthick

|Dec 21, 2017
Impact of the G84E variant on HOXB13 gene and protein expression in formalin-fixed, paraffin-embedded prostate tumours.

Liesel M FitzGerald, Kelsie Raspin, James R Marthick

Pageof 1